Systemic Lupus Erythematosus: Targeted Literature Review of the Epidemiology, Current Treatment, and Disease Burden in the Asia Pacific Region-Reference-Cited by-同舟云学术

Systemic Lupus Erythematosus: Targeted Literature Review of the Epidemiology, Current Treatment, and Disease Burden in the Asia Pacific Region

Published:2022-01-10 Issue:2 Volume:74 Page:187-198
ISSN:2151-464X
Container-title:Arthritis Care & Research
language:en
Short-container-title:Arthritis Care & Research

Author:

Tanaka Yoshiya¹^ORCID,O'Neill Sean²,Li Mengtao³^ORCID,Tsai I‐Ching⁴,Yang Ya‐Wen⁵^ORCID

Affiliation:

1. School of Medicine, University of Occupational and Environmental Health, Japan Kitakyushu Japan

2. Royal North Shore Hospital, The University of Sydney Northern Clinical School St Leonards New South Wales Australia

3. Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, National Clinical Research Center for Immunologic Diseases Ministry of Science & Technology, and Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education Beijing China

4. Janssen Pharmaceutical Companies of Johnson & Johnson Taipei City Taiwan

5. Global Medical Affairs, Janssen Pharmaceutical Companies of Johnson & Johnson

Publisher

Wiley

Subject

Rheumatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/acr.24431

Reference106 articles.

1. Decision Resources Group.Insights Report systemic lupus erythematosus disease landscape &f forecast. 2018. URL:https://decisionresourcesgroup.com/report/716479-biopharma-systemic-lupus-erythematosus-landscape/.

2. The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies

3. Systematic review of the epidemiology of systemic lupus erythematosus in the Asia-Pacific region: Prevalence, incidence, clinical features, and mortality

4. A systematic review of prevalence, disease characteristics and management of systemic lupus erythematosus in Australia: identifying areas of unmet need

5. One year in review 2017: systemic lupus erythematosus;La Paglia GM;Clin Exp Rheumatol,2017

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the contribution of genetics on the clinical manifestations of systemic lupus erythematosus;Best Practice & Research Clinical Rheumatology;2024-07

2. Integrative analysis of COL6A3 in lupus nephritis: insights from single-cell transcriptomics and proteomics;Frontiers in Immunology;2024-05-24

3. Safety, Pharmacokinetics, Biomarker Response, and Efficacy of E6742, a Dual Antagonist of Toll-Like Receptors 7 and 8, in a First-in-Patient, Randomized, Double-Blind, Phase 1/2 Study in Systemic Lupus Erythematosus;2024-04-27

4. Positive psychological capital, post-traumatic growth, social support, and quality of life in patients with systemic lupus erythematosus: A cross-sectional study;Lupus;2024-03-05

5. Asia‐Inclusive Global Development of Enpatoran: Results of an Ethno‐Bridging Study, Intrinsic/Extrinsic Factor Assessments and Disease Trajectory Modeling to Inform Design of a Phase II Multiregional Clinical Trial;Clinical Pharmacology & Therapeutics;2024-02-28